• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项用于治疗儿童复发性艰难梭菌感染的胃内粪菌移植方案具有疗效好、安全性高且费用低廉的特点。

An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.

机构信息

Section of Gastroenterology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Children's Hospital Colorado, Aurora, CO.

Section of Gastroenterology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Children's Hospital Colorado, Aurora, CO.

出版信息

J Pediatr. 2018 Mar;194:123-127.e1. doi: 10.1016/j.jpeds.2017.10.016. Epub 2017 Dec 1.

DOI:10.1016/j.jpeds.2017.10.016
PMID:29198534
Abstract

OBJECTIVE

To assess the safety, efficacy, and relative expense of a nurse-led fecal microbiota transplantation (FMT) program for the treatment of recurrent Clostridium difficile infection (CDI).

STUDY DESIGN

Retrospective cohort study design in children aged 1-18 years with recurrent CDI. The intervention was an intragastric FMT with stool derived from a donor stool bank. Primary outcome was resolution of diarrhea at 3 months post-transplantation. A secondary analysis compared charge data associated with FMT by intragastric delivery vs administration by colonoscopy or nasoduodenal tube.

RESULTS

A total of 47 intragastric FMT procedures were performed in 42 children (median age 9 years) with recurrent CDI. Response to treatment varied by disease status, with 94% success in previously healthy children, 75% in medically complex children, and 54% in children with inflammatory bowel disease (P = .04). FMT via intragastric delivery showed lower facility and professional charges by 85% and 78% compared with delivery via colonoscopy and radiology-placed nasoduodenal tube, respectively. The use of stool derived from a donor stool bank decreased charges by 49% compared with charges associated with the use of a donor who was a relative.

CONCLUSION

A nurse-led intragastric FMT procedure using stool derived from a donor stool bank is a relatively inexpensive and efficacious treatment for recurrent CDI in children. Intragastric FMT success in children was attenuated by the presence of underlying disease, particularly inflammatory bowel disease.

摘要

目的

评估由护士主导的粪便微生物群移植(FMT)方案治疗复发性艰难梭菌感染(CDI)的安全性、疗效和相对费用。

研究设计

对 1-18 岁复发性 CDI 患儿进行回顾性队列研究。干预措施是通过胃内途径给予来自供体粪便库的粪便进行 FMT。主要结局是移植后 3 个月腹泻缓解。二次分析比较了胃内途径给药与结肠镜或经鼻十二指肠管给药的 FMT 相关费用数据。

结果

共对 42 例复发性 CDI 患儿进行了 47 例胃内 FMT 操作(中位年龄为 9 岁)。治疗反应因疾病状态而异,既往健康的患儿成功率为 94%,医疗复杂的患儿为 75%,炎症性肠病患儿为 54%(P=0.04)。与结肠镜和放射科放置的经鼻十二指肠管相比,胃内途径给药的设施和专业费用分别降低了 85%和 78%。与使用亲属来源的粪便相比,使用来自供体粪便库的粪便可降低 49%的费用。

结论

由护士主导的、使用来自供体粪便库的粪便的胃内 FMT 操作是治疗儿童复发性 CDI 的一种相对廉价且有效的方法。儿童胃内 FMT 的成功率因潜在疾病的存在而降低,特别是炎症性肠病。

相似文献

1
An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.一项用于治疗儿童复发性艰难梭菌感染的胃内粪菌移植方案具有疗效好、安全性高且费用低廉的特点。
J Pediatr. 2018 Mar;194:123-127.e1. doi: 10.1016/j.jpeds.2017.10.016. Epub 2017 Dec 1.
2
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.粪便微生物群移植对多次复发性艰难梭菌感染复发的影响:一项随机试验
Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23.
3
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
4
Five years of fecal microbiota transplantation - an update of the Israeli experience.五年粪便微生物移植——以色列经验更新。
World J Gastroenterol. 2018 Dec 21;24(47):5403-5414. doi: 10.3748/wjg.v24.i47.5403.
5
Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).粪便微生物移植(FMT)成功根除艰难梭菌后胃肠道症状的危险因素。
J Clin Gastroenterol. 2019 Oct;53(9):e405-e408. doi: 10.1097/MCG.0000000000001194.
6
Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.粪便微生物群移植成功治疗艰难梭菌感染
J Physiol Pharmacol. 2016 Dec;67(6):859-866.
7
Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.在儿童中,单次粪便微生物群移植后,艰难梭菌持续根除与微生物组变化的关系,无论是否患有炎症性肠病。
Aliment Pharmacol Ther. 2015 Sep;42(6):741-52. doi: 10.1111/apt.13326. Epub 2015 Jul 21.
8
Fecal microbiota transplantation for the treatment of Clostridium difficile infection.粪便微生物群移植治疗艰难梭菌感染
J Hosp Med. 2016 Jan;11(1):56-61. doi: 10.1002/jhm.2449. Epub 2015 Sep 7.
9
A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.复发性艰难梭菌感染粪便微生物移植方法的回顾性比较
Isr Med Assoc J. 2016 Oct;18(10):594-599.
10
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.完全微生物群植入对于粪便微生物群移植后复发性艰难梭菌感染的恢复并非必不可少。
mBio. 2016 Dec 20;7(6):e01965-16. doi: 10.1128/mBio.01965-16.

引用本文的文献

1
Clostridioides difficile Infections: Prevention and Treatment Strategies.艰难梭菌感染:预防与治疗策略。
Adv Exp Med Biol. 2024;1449:175-186. doi: 10.1007/978-3-031-58572-2_11.
2
Colonic Endoscopic Tubing Is Safe and Effective Approach for Washed Microbiota Transplantation in Autistic Children.结肠内镜管是自闭症儿童洗肠微生物群移植的安全有效方法。
Gastroenterol Res Pract. 2023 Nov 22;2023:7838601. doi: 10.1155/2023/7838601. eCollection 2023.
3
Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of Infection among Pediatric Patients: A Systematic Review and Meta-Analysis.
粪便微生物群移植治疗小儿患者感染的疗效和安全性:一项系统评价和荟萃分析
Microorganisms. 2022 Dec 12;10(12):2450. doi: 10.3390/microorganisms10122450.
4
Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients.粪便微生物移植和微生物治疗在儿科患者艰难梭菌感染治疗中的应用。
J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S58-S63. doi: 10.1093/jpids/piab056.
5
Current and future applications of fecal microbiota transplantation for children.粪便微生物群移植在儿童中的应用现状和未来展望。
Biomed J. 2022 Feb;45(1):11-18. doi: 10.1016/j.bj.2021.11.004. Epub 2021 Nov 12.
6
Zootherapeutic uses of animals excreta: the case of elephant dung and urine use in Sayaboury province, Laos.动物粪便的动物治疗用途:以老挝沙耶武里省为例,探讨大象粪便和尿液的使用。
J Ethnobiol Ethnomed. 2021 Oct 28;17(1):62. doi: 10.1186/s13002-021-00484-7.
7
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.治疗后莱姆病患者的独特微生物组特征。
mBio. 2020 Sep 29;11(5):e02310-20. doi: 10.1128/mBio.02310-20.
8
Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report.心脏移植后幼儿粪菌移植治疗复发性艰难梭菌感染:一例报告。
Pediatr Transplant. 2020 Feb;24(1):e13598. doi: 10.1111/petr.13598. Epub 2019 Oct 16.
9
An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.儿童艰难梭菌感染的粪便微生物群移植的传染病学观点。
J Pediatric Infect Dis Soc. 2019 Dec 27;8(6):580-584. doi: 10.1093/jpids/piz062.
10
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.粪便微生物移植治疗儿童艰难梭菌感染的疗效。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):612-619.e1. doi: 10.1016/j.cgh.2019.04.037. Epub 2019 Apr 19.